Biologics/Immunotherapy News

Adolescents aged 12 to 17 years with allergic rhinitis induced by house dust mites now can take a sublingual immunotherapy tablet approved by the FDA after review of multiple trials in this age group.

The FDA approved house dust mite allergen extract tablet for sublingual immunotherapy treatment of house dust mite-induced allergic rhinitis in patients aged 12 to 17 years, according to a press release from the manufacturer.

Mepolizumab use was associated with fewer exacerbations, reduced oral corticosteroid use and lower costs among patients with asthma on Medicaid, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

OIT that began with boiled peanuts before moving to roasted peanuts appeared pragmatic, safe and effective in inducing desensitization among children with peanut allergy, according to a study published in Clinical & Experimental Allergy.

There was no statistical difference in overall risk for systemic reaction between standard and cluster subcutaneous allergen immunotherapy schedules, according to a study published in Annals of Allergy, Asthma & Immunology.

Long-term treatment with dupilumab appeared effective among patients with asthma with or without coexisting chronic rhinosinusitis with nasal polyps, according to a study published in Annals of Allergy, Asthma & Immunology.

Dupilumab facilitated the reversal of persistent airflow obstruction and improved clinical outcomes among patients with uncontrolled moderate to severe asthma, according to a post-hoc analysis in Annals of Allergy, Asthma & Immunology.

The severity of previous reactions can predict the potential need for epinephrine treatment during home administration of OIT for food allergy, according to a study published in Annals of Allergy, Asthma & Immunology.

Nearly all the patients on peanut OIT chose dietary peanut products instead of protein powder to continue treatment upon reaching maintenance dosing, according to a letter published in Annals of Allergy, Asthma & Immunology.

Researchers continued to investigate how to help allergy and asthma patients breathe easier, eat better, and live safer and more satisfying lives in 2022. Here are our top 10 stories about these developments this year.